API Holdings Ltd

API Holdings Ltd

Fortune 500 2024
OVERVIEW
FINANCIALS

About

API Holdings Limited, established in 2019, is one of India’s largest digital healthcare platforms. The company operates out of Mumbai, Maharashtra through an integrated, end-to-end business model that leverages advanced technology to address healthcare needs. The founding team initially supplied pharmaceutical products to pharmacies under the company Ascent before consolidating their various brands under API Holdings in 2019. The company owns several prominent brands, including PharmEasy, Docon, and Retailio. In 2021, the company acquired Medicare, Thyrocare, Aknamed and a 49% stake in Marg. Through these acquisitions, API Holdings became a diagnostics provider and a supplier of specialty medicinal drugs and devices, thus establishing a seamless and comprehensive healthcare ecosystem.

Incorporation Year: 2019
Headquarters: Mumbai, Maharashtra
Top Management: Siddharth Shah
Industry: Healthcare - Ancillary

Featured In Fortune India Ranking

#384(2024)

Financial Data 2024

Revenue
5,617
(INR Cr)
Net Operating Income
5,664
(INR Cr)
Assets
6,819
(INR Cr)
Profit
-2,550
(INR Cr)
Net Worth
2,189
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS20242023202220212020
Revenue
(INR Cr)
5617
-15.4%
6638
517.9%
1074
-56.6%
2475
211.1%
796
-
Net Operating Income
(INR Cr)
5664
-14.75%
6644
0.00%
872
1,628.07%
2335
249.83%
668
0.00%
Profit
(INR Cr)
-2550
-
-5230
-
-5232
-
-636
-
-335
-
Assets
(INR Cr)
6819
1.7%
6706
-0.5%
6737
57.4%
4281
785.7%
483
-
Net Worth
(INR Cr)
2189
4.6%
2092
0.0%
6318
53.5%
3439
1296.8%
246
0.0%
Employee Cost
(INR Cr)
699
-45.5%
1283
93.7%
662
145.1%
270
97.0%
137
-
Interest Cost
(INR Cr)
731672514512
Cash & Bank Balance
(INR Cr)
161029813732359
Total Debt
(INR Cr)
42193708296684224

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS20242023202220212020
Profit As % Of Revenues -----
Profit As % Of Assets -----
Profit As % Of Networth -----
Interest Cost to EBITDA % -----
Debt to Equity Ratio 1.931.770.050.200.91
RONW -----
ROCE 0.0%0.0%0.0%0.0%0.0%